title: Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness.
abstract: Mechanisms by which hepatitis C virus (HCV) evades cellular immunity to establish persistence in chronically infected individuals are not clear. Mutations in human leukocyte antigen (HLA) class I-restricted epitopes targeted by CD8(+) T cells are associated with persistence, but the extent to which these mutations affect viral fitness is not fully understood. Previous work showed that the HCV quasispecies in a persistently infected chimpanzee accumulated multiple mutations in numerous class I epitopes over a period of 7 years. During the acute phase of infection, one representative epitope in the C-terminal region of the NS3/4A helicase, NS3(1629-1637), displayed multiple serial amino acid substitutions in major histocompatibility complex (MHC) anchor and T cell receptor (TCR) contact residues. Only one of these amino acid substitutions at position 9 (P9) of the epitope was stable in the quasispecies. We therefore assessed the effect of each mutation observed during in vivo infection on viral fitness and T cell responses using an HCV subgenomic replicon system and a recently developed in vitro infectious virus cell culture model. Mutation of a position 7 (P7) TCR-contact residue, I1635T, expectedly ablated the T cell response without affecting viral RNA replication or virion production. In contrast, two mutations at the P9 MHC-anchor residue abrogated antigen-specific T cell responses, but additionally decreased viral RNA replication and virion production. The first escape mutation, L1637P, detected in vivo only transiently at 3 mo after infection, decreased viral production, and reverted to the parental sequence in vitro. The second P9 variant, L1637S, which was stable in vivo through 7 years of follow-up, evaded the antigen-specific T cell response and did not revert in vitro despite being less optimal in virion production compared to the parental virus. These studies suggest that HCV escape mutants emerging early in infection are not necessarily stable, but are eventually replaced with variants that achieve a balance between immune evasion and fitness for replication.
authors.affiliation: Department of Medicine, Division of Infectious Diseases, Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, United States of America.
authors.forename: Luke
authors.initials: L
authors.lastname: Uebelhoer
authors.forename: Jin-Hwan
authors.initials: JH
authors.lastname: Han
authors.forename: Benoit
authors.initials: B
authors.lastname: Callendret
authors.forename: Guaniri
authors.initials: G
authors.lastname: Mateu
authors.forename: Naglaa H
authors.initials: NH
authors.lastname: Shoukry
authors.forename: Holly L
authors.initials: HL
authors.lastname: Hanson
authors.forename: Charles M
authors.initials: CM
authors.lastname: Rice
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Walker
authors.forename: Arash
authors.initials: A
authors.lastname: Grakoui
mesh_terms: D045744:Cell Line, Tumor; D016174:Hepacivirus / Q000235:genetics* / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular; D009154:Mutation; D012641:Selection, Genetic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000821:virology*; D014779:Virus Replication
references.citation: J Exp Med. 2005 Jun 6;201(11):1725-31
references.pmid: 15939788
references.citation: J Immunol. 2002 Sep 15;169(6):3447-58
references.pmid: 12218168
references.citation: J Exp Med. 2004 Nov 15;200(10):1243-56
references.pmid: 15545352
references.citation: Transplantation. 1996 Jul 27;62(2):147-54
references.pmid: 8755808
references.citation: Gastroenterology. 2001 Feb;120(2):512-24
references.pmid: 11159892
references.citation: N Engl J Med. 1992 Dec 31;327(27):1899-905
references.pmid: 1280771
references.citation: J Exp Med. 2004 Dec 20;200(12):1593-604
references.pmid: 15611288
references.citation: Virology. 1999 Sep 15;262(1):250-63
references.pmid: 10489358
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9
references.pmid: 15939869
references.citation: Nat Med. 1999 Nov;5(11):1270-6
references.pmid: 10545993
references.citation: Immunol Lett. 2003 Jan 22;85(2):165-71
references.pmid: 12527224
references.citation: J Exp Med. 2005 Jun 6;201(11):1741-52
references.pmid: 15939790
references.citation: J Virol. 2003 Jun;77(12):6743-52
references.pmid: 12767994
references.citation: Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1294-8
references.pmid: 7509068
references.citation: J Virol. 2002 Dec;76(24):12423-34
references.pmid: 12438568
references.citation: World J Gastroenterol. 2007 Sep 28;13(36):4848-57
references.pmid: 17828816
references.citation: J Virol. 2007 Nov;81(22):12608-18
references.pmid: 17728232
references.citation: Science. 1999 Jul 2;285(5424):110-3
references.pmid: 10390360
references.citation: Nat Med. 2004 Mar;10(3):282-9
references.pmid: 14770175
references.citation: J Viral Hepat. 1999 Jan;6(1):35-47
references.pmid: 10847128
references.citation: Minerva Gastroenterol Dietol. 2004 Mar;50(1):21-8
references.pmid: 15719003
references.citation: Gastroenterology. 2003 Dec;125(6):1808-17
references.pmid: 14724833
references.citation: Science. 2005 Jul 22;309(5734):623-6
references.pmid: 15947137
references.citation: Immunity. 2001 Dec;15(6):883-95
references.pmid: 11754811
references.citation: CSH Protoc. 2006 Jul 01;2006(2):
references.pmid: 22485828
references.citation: J Clin Invest. 1997 Nov 1;100(9):2376-85
references.pmid: 9410918
references.citation: Nature. 1991 Dec 12;354(6353):453-9
references.pmid: 1721107
references.citation: Semin Liver Dis. 1995 Feb;15(1):41-63
references.pmid: 7597443
references.citation: Gastroenterology. 1998 Oct;115(4):954-65
references.pmid: 9753499
references.citation: J Virol. 2004 Mar;78(5):2581-5
references.pmid: 14963161
references.citation: J Virol. 2004 Dec;78(24):13901-10
references.pmid: 15564498
references.citation: J Exp Med. 2005 Jun 6;201(11):1753-9
references.pmid: 15939791
references.citation: Nat Med. 2004 Mar;10(3):275-81
references.pmid: 14966520
references.citation: Nat Med. 2005 Jul;11(7):791-6
references.pmid: 15951748
references.citation: J Exp Med. 2001 Nov 19;194(10):1395-406
references.pmid: 11714747
references.citation: Lancet. 1995 Oct 14;346(8981):1006-7
references.pmid: 7475549
references.citation: J Exp Med. 2003 May 19;197(10):1365-75
references.pmid: 12743169
references.citation: Nature. 2000 Sep 21;407(6802):386-90
references.pmid: 11014195
references.citation: Gut. 2006 Feb;55(2):266-74
references.pmid: 16105887
references.citation: Virology. 2008 Jul 5;376(2):397-407
references.pmid: 18455749
references.citation: J Exp Med. 2000 May 1;191(9):1499-512
references.pmid: 10790425
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8
references.pmid: 12441397
references.citation: J Virol. 2006 Apr;80(7):3617-23
references.pmid: 16537629
references.citation: J Immunol. 1999 May 1;162(9):5584-91
references.pmid: 10228041
references.citation: Science. 2000 Dec 8;290(5498):1972-4
references.pmid: 11110665
references.citation: Eur J Immunol. 2005 Sep;35(9):2627-37
references.pmid: 16114108
references.citation: Science. 1998 Oct 2;282(5386):103-7
references.pmid: 9756471
references.citation: Immunity. 1999 Apr;10(4):439-49
references.pmid: 10229187
references.citation: Science. 2000 Apr 14;288(5464):339-44
references.pmid: 10764648
references.citation: J Clin Invest. 2004 Jul;114(2):250-9
references.pmid: 15254592
references.citation: Nat Med. 1997 Feb;3(2):205-11
references.pmid: 9018240
references.citation: N Engl J Med. 1999 Aug 19;341(8):556-62
references.pmid: 10451460
references.citation: Semin Liver Dis. 2000;20(1):1-16
references.pmid: 10895428